Patient Sex, Reproductive Status, and Synthetic Hormone Use Associate With Histologic Severity of Nonalcoholic Steatohepatitis
- PMID: 27523635
- PMCID: PMC5161542
- DOI: 10.1016/j.cgh.2016.07.034
Patient Sex, Reproductive Status, and Synthetic Hormone Use Associate With Histologic Severity of Nonalcoholic Steatohepatitis
Abstract
Background & aims: Sex and sex hormones can affect responses of patients with nonalcoholic fatty liver disease (NAFLD) to metabolic stress and development of hepatocyte injury and inflammation.
Methods: We collected data from 3 large U.S. studies of patients with NAFLD (between October 2004 and June 2013) to assess the association between histologic severity and sex, menopause status, synthetic hormone use, and menstrual abnormalities in 1112 patients with a histologic diagnosis of NAFLD. We performed logistic or ordinal logistic regression models, adjusting for covariates relevant to an increase of hepatic metabolic stress.
Results: Premenopausal women were at an increased risk of lobular inflammation, hepatocyte ballooning, and Mallory-Denk bodies than men and also at an increased risk of lobular inflammation and Mallory-Denk bodies than postmenopausal women (P < .01). Use of oral contraceptives was associated with an increased risk of lobular inflammation and Mallory-Denk bodies in premenopausal women, whereas hormone replacement therapy was associated with an increased risk of lobular inflammation in postmenopausal women (P < .05).
Conclusions: Being a premenopausal woman or a female user of synthetic hormones is associated with increased histologic severity of hepatocyte injury and inflammation among patients with NAFLD at given levels of hepatic metabolic stress.
Keywords: Fibrosis; Gender Differences; Risk Factor Analysis.
Copyright © 2017 AGA Institute. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
The authors do not have conflict of interest related to this work.
Comment in
-
Patient Sex, Reproductive Status, and Synthetic Hormone Use Associate With Histologic Severity of Nonalcoholic Steatohepatitis.Clin Gastroenterol Hepatol. 2017 Sep;15(9):1479. doi: 10.1016/j.cgh.2017.02.036. Epub 2017 Mar 12. Clin Gastroenterol Hepatol. 2017. PMID: 28300690 No abstract available.
-
Reply.Clin Gastroenterol Hepatol. 2018 Oct;16(10):1684. doi: 10.1016/j.cgh.2017.05.003. Epub 2017 May 11. Clin Gastroenterol Hepatol. 2018. PMID: 28502788 No abstract available.
References
-
- Kojima S, Watanabe N, Numata M, et al. Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical background. J Gastroenterol. 2003;38:954–61. - PubMed
-
- Clark JM, Brancati FL, Diehl AM. The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol. 2003;98:960–7. - PubMed
-
- Park SH, Jeon WK, Kim SH, et al. Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults. J Gastroenterol Hepatol. 2006;21:138–43. - PubMed
-
- Clark JM, Brancati FL, Diehl AM. Nonalcoholic fatty liver disease. Gastroenterology. 2002;122:1649–57. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- U01 DK061731/DK/NIDDK NIH HHS/United States
- U01 DK061718/DK/NIDDK NIH HHS/United States
- UL1 TR000006/TR/NCATS NIH HHS/United States
- UL1 TR000436/TR/NCATS NIH HHS/United States
- UL1 TR001422/TR/NCATS NIH HHS/United States
- U01 DK061730/DK/NIDDK NIH HHS/United States
- U01 DK061728/DK/NIDDK NIH HHS/United States
- UL1 TR000439/TR/NCATS NIH HHS/United States
- UL1 TR000454/TR/NCATS NIH HHS/United States
- UL1 TR000448/TR/NCATS NIH HHS/United States
- UL1 TR000004/TR/NCATS NIH HHS/United States
- U01 DK061737/DK/NIDDK NIH HHS/United States
- U01 DK061713/DK/NIDDK NIH HHS/United States
- U01 DK061732/DK/NIDDK NIH HHS/United States
- UL1 TR000150/TR/NCATS NIH HHS/United States
- UL1 TR000058/TR/NCATS NIH HHS/United States
- UL1 TR001108/TR/NCATS NIH HHS/United States
- U01 DK061738/DK/NIDDK NIH HHS/United States
- UL1 TR000424/TR/NCATS NIH HHS/United States
- U01 DK061734/DK/NIDDK NIH HHS/United States
- UL1 TR002319/TR/NCATS NIH HHS/United States
- UL1 TR000040/TR/NCATS NIH HHS/United States
- UL1 TR000077/TR/NCATS NIH HHS/United States
- UL1 TR000423/TR/NCATS NIH HHS/United States
- UL1 TR000100/TR/NCATS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
